118 Complex Antithrombotic Therapy (CAT) and National Risk of Upper Gastrointestinal Bleeding (UGIB), Lower Gastrointestinal Bleeding (LGIB), Transfusions and Hospitalizations

2012 ◽  
Vol 142 (5) ◽  
pp. S-28 ◽  
Author(s):  
Neena Abraham ◽  
Aanand D. Naik ◽  
Peter Richardson ◽  
Christine M. Hartman
2013 ◽  
Vol 144 (5) ◽  
pp. S-510-S-511
Author(s):  
Maria E. Saez ◽  
Antonio Gonzalez-Perez ◽  
Saga Johansson ◽  
Péter Nagy ◽  
Luis A. Garcia Rodriguez

Circulation ◽  
2013 ◽  
Vol 128 (17) ◽  
pp. 1869-1877 ◽  
Author(s):  
Neena S. Abraham ◽  
Christine Hartman ◽  
Peter Richardson ◽  
Diana Castillo ◽  
Richard L. Street ◽  
...  

BMJ ◽  
2006 ◽  
Vol 333 (7571) ◽  
pp. 726 ◽  
Author(s):  
Jesper Hallas ◽  
Michael Dall ◽  
Alin Andries ◽  
Birthe Søgaard Andersen ◽  
Claus Aalykke ◽  
...  

Blood ◽  
2005 ◽  
Vol 106 (11) ◽  
pp. 4131-4131
Author(s):  
Aref Agheli ◽  
Alka Arora ◽  
Maged Khalil ◽  
Seema Naik ◽  
Theresa Dumlao ◽  
...  

Abstract Isolated, also called idiopathic, splenic vein thrombosis (SVT) is a very rare clinical condition, which usually results in left-sided portal hypertension and isolated fundal varices. This syndrome is a rare cause of mostly upper, gastrointestinal bleeding. There are only a few hundreds of cases reported in the literature. Colonic varices are even much rarer, 0.07% post mortem autopsies, and 0.2% in a prospective large endoscopic trials. Pancreatic disorders, including malignancies are the most common underlying causes for SVT. Congenital aneurysm of the splenic vein is one of the theoretical explanations of the Isolated, Idiopathic SVT. Case report: A 53 year old Caucasian female with history of hypertension, and no history of smoking or alcohol abuse, presented with chronic lower gastrointestinal bleeding. Upper endoscopy and flexible colonoscopy revealed perigastric varices without any source of acute bleeding. A bleeding scan demonstrated marked splenomegaly and source of bleeding from left colon. Mesenteric angiogram during venous phase showed splenic vein thrombosis and extensive perigastric varices. In addition, a single large left colonic varix from the lower pole of the spleen was identified as the source of bleeding. The patient was treated with splenic artery embolization with coils, followed by splenectomy, without any major complication. Coagulation studies 8 weeks after the procedure did not show any hypercoagulable state. Conclusion: The Isolated, Idiopathic SVT, itself is a very rare syndrome. Our center has reported four cases of SVT, secondary to medical conditions, such as; pancreatic malignancy, MRSA sepsis, and multi-organ failure. Upper gastrointestinal bleeding has been more frequently reported than lower bleeding. Interestingly, in our case report, a single colonic varix secondary to SVT was proved to be the cause of chronic lower gastrointestinal bleeding. SVT should be suspected in any patient with a triad of gastric varices, splenomegaly, and normal liver function tests, who presents with gastrointestinal bleeding secondary to left sided or so called “sinistral” portal hypertension. Mesenteric angiography with venous phase is the gold standard for the diagnosis of SVT, as endoscopic studies may not be diagnostic of this syndrome. Splenectomy is the only and definitive procedure of choice in the patients with isolated SVT, followed by post splenectomy vaccination.


2013 ◽  
Vol 79 (4) ◽  
pp. 375-380 ◽  
Author(s):  
William S. Yi ◽  
Gaurav Garg ◽  
Jack A. Sava

Angiography has long been a mainstay of lower gastrointestinal bleeding localization. More recently, angioembolism has been used therapeutically for bleeding control, but there are limited data on its efficacy. This study was designed to evaluate the efficacy of angiography and embolization for localizing and treating lower gastrointestinal bleeding as well evaluate the occurrence of bowel ischemia after embolization. This study is a retrospective descriptive review of all patients undergoing mesenteric angiography at a tertiary hospital over an eight-year period. Clinical data were recorded including patient demographics, causes of bleeding, procedures, and outcomes. Patients were excluded if the cause of bleeding was upper gastrointestinal bleeding or the medical record was missing data. Localization and definitive control of bleeding was the primary end point. One hundred fifty-nine angiograms were performed on 152 patients. Mean age was 72 years. Angiographic localization was successful in 23.7 per cent of patients. Although embolization after angiographic localization achieved definitive control of bleeding in 50 per cent of patients, the success rate was only 8.6 per cent of all patients who had angiography. One patient developed postembolization ischemia requiring laparotomy. Angiographic localization of lower gastrointestinal bleeding is successful in only 23.7 per cent of patients. Definitive hemostasis through embolization was successful in only 8.6 per cent of patients who underwent angiography for lower gastrointestinal bleeding.


2017 ◽  
Vol 94 (1109) ◽  
pp. 137-142 ◽  
Author(s):  
Keith Siau ◽  
Jack L Hannah ◽  
James Hodson ◽  
Monika Widlak ◽  
Neeraj Bhala ◽  
...  

IntroductionAntithrombotic drugs are often stopped following acute upper gastrointestinal bleeding (AUGIB) and frequently not restarted. The practice of antithrombotic discontinuation on discharge and its impact on outcomes are unclear.ObjectiveTo assess whether restarting antithrombotic therapy, prior to hospital discharge for AUGIB, affected clinical outcomes.DesignRetrospective cohort study.SettingUniversity hospital between May 2013 and November 2014, with median follow-up of 259 days.PatientsPatients who underwent gastroscopy for AUGIB while on antithrombotic therapy.InterventionsContinuation or cessation of antithrombotic(s) at discharge.Main outcomes measuresCause-specific mortality, thrombotic events, rebleeding and serious adverse events (any of the above).ResultsOf 118 patients analysed, antithrombotic treatment was stopped in 58 (49.2%). Older age, aspirin monotherapy and peptic ulcer disease were significant predictors of antithrombotic discontinuation, whereas dual antiplatelet use predicted antithrombotic maintenance. The 1-year postdischarge mortality rate was 11.3%, with deaths mainly due to thrombotic causes. Stopping antithrombotic therapy at the time of discharge was associated with increased mortality (HR 3.32; 95% CI 1.07 to 10.31, P=0.027), thrombotic events (HR 5.77; 95% CI 1.26 to 26.35, P=0.010) and overall adverse events (HR 2.98; 95% CI 1.32 to 6.74, P=0.006), with effects persisting after multivariable adjustment for age and peptic ulcer disease. On subgroup analysis, the thromboprotective benefit remained significant with continuation of non-aspirin regimens (P=0.016). There were no significant differences in postdischarge bleeding rates between groups (HR 3.43, 0.36 to 33.04, P=0.255).ConclusionIn this hospital-based study, discontinuation of antithrombotic therapy is associated with increased thrombotic events and reduced survival.


Author(s):  
Ji Hye Kwak ◽  
Cha Young Kim ◽  
Hong Jun Kim ◽  
Chang Yoon Ha ◽  
Hyun Jin Kim ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document